Literature DB >> 17956642

Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.

J Mossong1, N Hens, V Friederichs, I Davidkin, M Broman, B Litwinska, J Siennicka, A Trzcinska, P VAN Damme, P Beutels, A Vyse, Z Shkedy, M Aerts, M Massari, G Gabutti.   

Abstract

We conducted a seroprevalence survey in Belgium, Finland, England & Wales, Italy and Poland on 13 449 serum samples broadly representative in terms of geography and age. Samples were tested for the presence of immunoglobulin G antibody using an enzyme immunoassay. The age-specific risk of infection was estimated using parametric and non-parametric statistical modelling. The age-specific risk in all five countries was highest in children aged 7-9 years and lower in adults. The average proportion of women of child-bearing age susceptible to parvovirus B19 infection and the risk of a pregnant women acquiring B19 infection during pregnancy was estimated to be 26% and 0.61% in Belgium, 38% and 0.69% in England & Wales, 43.5% and 1.24% in Finland, 39.9% and 0.92% in Italy and 36.8% and 1.58% in Poland, respectively. Our study indicates substantial epidemiological differences in Europe regarding parvovirus B19 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956642      PMCID: PMC2870907          DOI: 10.1017/S0950268807009661

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.

Authors:  J P Nascimento; M M Buckley; K E Brown; B J Cohen
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1990 Jan-Feb       Impact factor: 1.846

3.  Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.

Authors:  M Enders; A Weidner; G Enders
Journal:  Epidemiol Infect       Date:  2006-10-26       Impact factor: 2.451

4.  Modelling forces of infection for measles, mumps and rubella.

Authors:  C P Farrington
Journal:  Stat Med       Date:  1990-08       Impact factor: 2.373

5.  The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world.

Authors:  H A Kelly; D Siebert; R Hammond; J Leydon; P Kiely; W Maskill
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

6.  Human parvovirus B19 infections in women of childbearing age and within families.

Authors:  W C Koch; S P Adler
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

7.  Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections.

Authors:  W J Edmunds; C J O'Callaghan; D J Nokes
Journal:  Proc Biol Sci       Date:  1997-07-22       Impact factor: 5.349

8.  Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.

Authors:  W Ripley Ballou; Jennifer L Reed; William Noble; Neal S Young; Scott Koenig
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

9.  Estimation of infectious disease parameters from serological survey data: the impact of regular epidemics.

Authors:  H J Whitaker; C P Farrington
Journal:  Stat Med       Date:  2004-08-15       Impact factor: 2.373

10.  Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?

Authors:  N J Gay; L M Hesketh; B J Cohen; M Rush; C Bates; P Morgan-Capner; E Miller
Journal:  Commun Dis Rep CDR Rev       Date:  1994-08-19
View more
  22 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples.

Authors:  Xavier Bonjoch; Francesc Obispo; Cristina Alemany; Ana Pacha; Esteban Rodríguez; Dolors Xairó
Journal:  Transfus Med Hemother       Date:  2015-04-23       Impact factor: 3.747

3.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

4.  Epidemiological and clinical characteristics of human parvovirus B19 infections during 2006-2009 in Northern Greece.

Authors:  M Exindari; D Chatzidimitriou; A Melidou; G Gioula; L Ziogou; E Diza
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

5.  Safety and immunogenicity of a candidate parvovirus B19 vaccine.

Authors:  David I Bernstein; Hana M El Sahly; Wendy A Keitel; Mark Wolff; Gina Simone; Claire Segawa; Susan Wong; Daniel Shelly; Neal S Young; Walla Dempsey
Journal:  Vaccine       Date:  2011-07-30       Impact factor: 3.641

6.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

7.  Little Italy: an agent-based approach to the estimation of contact patterns- fitting predicted matrices to serological data.

Authors:  Fabrizio Iozzi; Francesco Trusiano; Matteo Chinazzi; Francesco C Billari; Emilio Zagheni; Stefano Merler; Marco Ajelli; Emanuele Del Fava; Piero Manfredi
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

8.  Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.

Authors:  Janak Kishore; Manisha Srivastava; Nabjyoti Choudhary
Journal:  Asian J Transfus Sci       Date:  2010-07

9.  High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.

Authors:  Colin P Sharp; Alice Lail; Sharyne Donfield; Ruth Simmons; Clifford Leen; Paul Klenerman; Eric Delwart; Edward D Gomperts; Peter Simmonds
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

10.  Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.

Authors:  Päivi Norja; Anna Maria Eis-Hübinger; Maria Söderlund-Venermo; Klaus Hedman; Peter Simmonds
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.